ScreenerHero

KIDSOrthoPediatrics Corp.

NAS · US · Healthcare · Medical Devices · orthopediatrics.com
26.25USD+2.34%Mkt Cap: 669.72M $P/E: —

OrthoPediatrics Corp., a medical device company, engages in designing, developing, and marketing anatomically appropriate implants, instruments, and specialized braces for children with orthopedic conditions in the Unite…

Industry Peers

Medical Devices
Screen all
ABT
Abbott Laboratories
$203.22BUSDP/E 37.8
SYK
Stryker Corporation
$125.74BUSDP/E 34.0
MDT
Medtronic plc
$118.91BUSDP/E 24.9
BSX
Boston Scientific Corporation
$71.03BUSDP/E 19.8
SHL
Siemens Healthineers AG
$48.43BUSDP/E 19.9
EW
Edwards Lifesciences Corporation
$52.11BUSDP/E 53.9
DXCM
DexCom, Inc.
$34.85BUSDP/E 36.5
GEHC
GE HealthCare Technologies Inc. Common Stock
$34.04BUSDP/E 17.2
PHIA
Koninklijke Philips N.V.
$25.08BUSDP/E 20.7
PHG
Koninklijke Philips N.V.
$26.90BUSDP/E 20.7
STE
STERIS plc
$23.19BUSDP/E 29.1
ZBH
Zimmer Biomet Holdings, Inc.
$19.26BUSDP/E 24.5
PEN
Penumbra, Inc.
$12.75BUSDP/E 79.7
SNN
Smith & Nephew plc
$12.40BUSDP/E 20.1
GMED
Globus Medical, Inc.
$11.29BUSDP/E 21.5
GKOS
Glaukos Corporation
$10.95BUSD
SN
Smith & Nephew plc
$9.84BUSDP/E 20.0
PODD
Insulet Corporation
$10.28BUSDP/E 27.5
BIO
Bio-Rad Laboratories, Inc.
$10.22BUSDP/E 46.5
DEMANT
Demant A/S
$8.82BUSDP/E 25.0
HeadlineSourceTime
Older
OrthoPediatrics Sees ‘Inflection Point’ as New Products Fuel Record Quarter

OrthoPediatrics (NASDAQ:KIDS) reported record revenue, adjusted EBITDA and number of children helped during the second quarter, as the pediatric orthopedic device company began to see early contributions from its newer “super cycle” products, Chief Executive Officer Dave Bailey said at the Canaccord

MarketBeat
OrthoPediatrics (KIDS) Q2 2026 Earnings Call Transcript

Trauma and deformity revenue surged 26% as adjusted EBITDA hit record $6.8 million.

Motley Fool
OrthoPediatrics Corp. Q2 2026 Earnings Call Summary

Moby summary of OrthoPediatrics Corp.'s Q2 2026 earnings call

Moby
OrthoPediatrics Corp (KIDS) (Q2 2026) Earnings Call Highlights: Record Revenue and EBITDA ...

OrthoPediatrics Corp (KIDS) posts 15% revenue growth and raises full-year guidance amid strong trauma and deformity performance.

GuruFocus.com
OrthoPediatrics Q2 Earnings Call Highlights

OrthoPediatrics (NASDAQ:KIDS) reported record second-quarter revenue of $70.5 million, up 15% from a year earlier, as strong Trauma & Deformity and specialty bracing performance offset a reported decline in scoliosis revenue. The company also raised its 2026 revenue outlook while maintaining its

MarketBeat
OrthoPediatrics (KIDS) Reports Q2 Loss, Tops Revenue Estimates

OrthoPediatrics (KIDS) delivered earnings and revenue surprises of +16.13% and +3.64%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

Zacks
OrthoPediatrics (KIDS) Stock Sees Split Analyst Revisions After Mixed Price Target Changes
Simply Wall St.
Why The OrthoPediatrics (KIDS) Narrative Is Evolving Without A New Price Target
Simply Wall St.
How The OrthoPediatrics (KIDS) Story Is Shifting As Analysts Reassess Growth And Valuation
Simply Wall St.
Is the Selloff in OrthoPediatrics Corp. (KIDS) Creating a Buying Opportunity?

Minot Light Capital Partners, an investment management company, released its “Capital Appreciation Fund” Q1 2026 Investor Letter. A copy of the letter can be downloaded here. The fund declined by 2.7% in the first quarter of 2026 due to a sharp macro-driven sector rotation following geopolitical tensions, which triggered inflation fears and rising interest rate […]

IInsider Monkey